Gastric H+, K+-ATPase

Comprehensive Physiology

Volumn 1, Issue 4, 2011, Pages 2141-2153

  Shin, Jai Moo ^a   Munson, Keith ^a   Sachs, George ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HYDROGEN POTASSIUM ADENOSINE TRIPHOSPHATASE; POTASSIUM; PROTON PUMP INHIBITOR;

AMINO ACID SEQUENCE; ANIMAL; ARTICLE; CHEMISTRY; HUMAN; METABOLISM; MOLECULAR DYNAMICS; MOLECULAR GENETICS;

AMINO ACID SEQUENCE; ANIMALS; H(+)-K(+)-EXCHANGING ATPASE; HUMANS; MOLECULAR DYNAMICS SIMULATION; MOLECULAR SEQUENCE DATA; POTASSIUM; PROTON PUMP INHIBITORS;

EID: 84862229175     PISSN: None     EISSN: 20404603     Source Type: Journal    
DOI: 10.1002/cphy.c110010     Document Type: Article

References (110)

1. Abe K, Tani K, Fujiyoshi Y. Conformational rearrangement of gastric H(+), K(+)-ATPase induced by an acid suppressant. Nat Commun 2: 155, 2011.
2. Abe K, Tani K, Nishizawa T, Fujiyoshi Y. Inter-subunit interaction of gastric H+, K+-ATPase prevents reverse reaction of the transport cycle. Embo J, 28, 2009, 1637-1643
3. Asano S, Kawada K, Kimura T, Grishin AV, Caplan MJ, Takeguchi N. The roles of carbohydrate chains of the beta-subunit on the functional expression of gastric H(+), K(+)-ATPase. J Biol Chem 275: 8324-8330, 2000.
4. Asano S, Mizutani M, Hayashi T, Morita N, Takeguchi N. Reversible inhibitions of gastric H+, K(+)-ATPase by scopadulcic acid B and diacetyl scopadol. New biochemical tools of H+, K(+)-ATPase. J Biol Chem, 265, 1990, 22167-22173
5. Bamberg K, Mercier F, Reuben MA, Kobayashi Y, Munson KB, Sachs G. cDNA cloning and membrane topology of the rabbit gastric H+/K(+)-ATPase alpha-subunit. Biochim Biophys Acta, 1131, 1992, 69-77
6. Bamberg K, Sachs G. Topological analysis of H+, K(+)-ATPase using in vitro translation. J Biol Chem, 269, 1994, 16909-16919
7. Besancon M, Shin JM, Mercier F, Munson K, Miller M, Hersey S, Sachs G. Membrane topology and omeprazole labeling of the gastric H+, K(+)- adenosinetriphosphatase. Biochemistry, 32, 1993, 2345-2355
8. Besancon M, Simon A, Sachs G, Shin JM. Sites of reaction of the gastric H, K-ATPase with extracytoplasmic thiol reagents. J Biol Chem, 272, 1997, 22438-22446
9. Brzezinski P, Malmstrom BG, Lorentzon P, Wallmark B. The catalytic mechanism of gastric H+/K+-ATPase: Simulations of pre-steady-state and steady-state kinetic results. Biochim Biophys Acta, 942, 1988, 215-219
10. Callaghan JM, Toh BH, Pettitt JM, Humphris DC, Gleeson PA. Poly-Nacetyllactosamine-specific tomato lectin interacts with gastric parietal cells. Identification of a tomato-lectin binding 60-90 X 10(3) Mr membrane glycoprotein of tubulovesicles. J Cell Sci 95 (Pt 4): 563-576, 1990.
11. Canfield VA, Levenson R. Structural organization and transcription of themouse gastric H+, K(+)-ATPase beta subunit gene. Proc Natl Acad Sci U S A, 88, 1991, 8247-8251
12. Canfield VA, Okamoto CT, Chow D, Dorfman J, Gros P, Forte JG, Levenson R. Cloning of the H, K-ATPase beta subunit. Tissue-specific expression, chromosomal assignment, and relationship toNa, K-ATPase beta subunits. J Biol Chem, 265, 1990, 19878-19884
13. Craig WS. Monomer of sodium and potassium ion activated adenosinetriphosphatase displays complete enzymatic function. Biochemistry, 21, 1982, 5707-5717
14. Dantzig AH, Minor PL, Garrigus JL, Fukuda DS, Mynderse JS. Studies on the mechanism of action of A80915A, a semi-naphthoquinone natural product, as an inhibitor of gastric (H(+)-K+)-ATPase. Biochem Pharmacol, 42, 1991, 2019-2026
15. De Pont JJ, Swarts HG, Karawajczyk A, Schaftenaar G, Willems PH, Koenderink JB. The non-gastric H, K-ATPase as a tool to study the ouabain-binding site in Na, K-ATPase. Pflugers Arch, 457, 2009, 623-634
16. Durr KL, Abe K, Tavraz NN, Friedrich T. E2P state stabilization by the N-terminal tail of the H, K-ATPase beta-subunit is critical for efficient proton pumping under in vivo conditions. J Biol Chem, 284, 2009, 20147-20154
17. Fellenius E, Berglindh T, Sachs G, Olbe L, Elander B, Sjostrand SE, Wallmark B. Substituted benzimidazoles inhibit gastric acid secretion by blocking (H++K+)ATPase. Nature, 290, 1981, 159-161
18. Fujisaki H, Shibata H, Oketani K, Murakami M, Fujimoto M, Wakabayashi T, Yamatsu I, Yamaguchi M, Sakai H, Takeguchi N. Inhibitions of acid secretion by E3810 and omeprazole, and their reversal by glutathione. Biochem Pharmacol, 42, 1991, 321-328
19. Hall K, Perez G, Anderson D, Gutierrez C, Munson K, Hersey SJ, Kaplan JH, Sachs G. Location of the carbohydrates present in the HKATPase vesicles isolated from hog gastric mucosa. Biochemistry, 29, 1990, 701-706
20. Hall K, Perez G, Sachs G, Rabon E. Identification of H+/K(+)-ATPase alpha,beta-heterodimers. Biochim Biophys Acta, 1077, 1991, 173-179
21. Han KS, Kim YG, Yoo JK, Lee JW, Lee MG. Pharmacokinetics of a new reversible proton pump inhibitor, YH1885, after intravenous and oral administrations to rats and dogs: Hepatic first-pass effect in rats. Biopharm Drug Dispos, 19, 1998, 493-500
22. Hebert H, Xian Y, Hacksell I, Mardh S. Two-dimensional crystals of membrane-bound gastric H, K-ATPase. FEBS Lett, 299, 1992, 159-162
23. Hioki Y, Takada J, Hidaka Y, Takeshita H, Hosoi M, Yano M. A newly synthesized pyridine derivative, (Z)-5-methyl-2-[2-(1-naphthyl)ethenyl]-4-piperidinopyridine hydrochloride (AU-1421), as a reversible gastric proton pump inhibitor. Arch Int Pharmacodyn Ther, 305, 1990, 32-44
24. Hori Y, Imanishi A, Matsukawa J, Tsukimi Y, Nishida H, Arikawa Y, Hirase K, Kajino M, Inatomi N. 1-[5-(2-Fluorophenyl)-1-(pyridin-3-ylsulfonyl)-1H-pyrrol-3-yl]-N-methylmet hanamine monofumarate (TAK-438), a novel and potent potassium-competitive acid blocker for the treatment of acid-related diseases. J Pharmacol Exp Ther, 335, 2011, 231-238
25. Hunt RH, Armstrong D, Yaghoobi M, James C, Chen Y, Leonard J, Shin JM, Lee E, Tang-Liu D, Sachs G. Predictable prolonged suppression of gastric acidity with a novel proton pump inhibitor, AGN 201904-Z. Aliment Pharmacol Ther, 28, 2008, 187-199
26. Ife RJ, Brown TH, Keeling DJ, Leach CA, Meeson ML, Parsons ME, Reavill DR, Theobald CJ, Wiggall KJ. Reversible inhibitors of the gastric (H+/K+)-ATPase. 3. 3-substituted-4- (phenylamino)quinolines. J Med Chem, 35, 1992, 3413-3422
27. Jensen AM, Sorensen TL, Olesen C, Moller JV, Nissen P. Modulatory and catalytic modes of ATP binding by the calcium pump. Embo J, 25, 2006, 2305-2314
28. Kaminski JJ, Bristol JA, Puchalski C, Lovey RG, Elliott AJ, Guzik H, Solomon DM, Conn DJ, Domalski MS, Wong SC, Gold EH, Long JF, Chiu PJ, Steinberg M, McPhail AT. Antiulcer agents. 1. Gastric antisecretory and cytoprotective properties of substituted imidazo[1,2-a]pyridines. J Med Chem, 28, 1985, 876-892
29. Kaminski JJ, Doweyko AM. Antiulcer agents. 6. Analysis of the in vitro biochemical and in vivo gastric antisecretory activity of substituted imidazo[1,2-a]pyridines and related analogues using comparative molecular field analysis and hypothetical active site lattice methodologies. J Med Chem, 40, 1997, 427-436
30. Katz PO, Koch FK, Ballard ED, Bagin RG, Gautille TC, Checani GC, Hogan DL, Pratha VS. Comparison of the effects of immediate-release omeprazole oral suspension, delayed-release lansoprazole capsules and delayed-release esomeprazole capsules on nocturnal gastric acidity after bedtime dosing in patients with night-time GERD symptoms. Aliment Pharmacol Ther, 25, 2007, 197-205
31. Keeling DJ, Fallowfield C, Underwood AH. The specificity of omeprazole as an (H++K+)-ATPase inhibitor depends upon the means of its activation. Biochem Pharmacol, 36, 1987, 339-344
32. Laine L, Katz PO, Johnson DA, Ibegbu I, Goldstein MJ, Chou C, Rossiter G, Lu Y. Randomised clinical trial: A novel rabeprazole extended release 50 mg formulation vs. esomeprazole 40 mg in healing of moderate-to-severe erosive oesophagitis - the results of two doubleblind studies. Aliment Pharmacol Ther, 33, 2011, 203-212
33. La Mattina JL, McCarthy PA, Reiter LA, Holt WF, Yeh LA. Antiulcer agents. 4-substituted 2-guanidinothiazoles: Reversible, competitive, and selective inhibitors of gastric H+, K(+)-ATPase. J Med Chem, 33, 1990, 543-552
34. Lane LK, Kirley TL, Ball WJ, Jr. Structural studies onH+, K+-ATPase: Determination of the NH2-terminal amino acid sequence and immunological cross-reactivity with Na+, K+-ATPase. Biochem Biophys Res Commun, 138, 1986, 185-192
35. Law RJ, Munson K, Sachs G, Lightstone FC. An ion gating mechanism of gastric H, K-ATPase based on molecular dynamics simulations. Biophys J, 95, 2008, 2739-2749
36. Leach CA, Brown TH, Ife RJ, Keeling DJ, Laing SM, Parsons ME, Price CA, Wiggall KJ. Reversible inhibitors of the gastric (H+/K+)-ATPase. 2. 1- Arylpyrrolo[3,2-c]quinolines: Effect of the 4-substituent. J Med Chem, 35, 1992, 1845-1852
37. Lorentzon P, Jackson R, Wallmark B, Sachs G. Inhibition of (H+ + K+)-ATPase by omeprazole in isolated gastric vesicles requires proton transport. Biochim Biophys Acta, 897, 1987, 41-51
38. Ma JY, Song YH, Sjostrand SE, Rask L, Mardh S. cDNA cloning of the beta-subunit of the human gastric H, K-ATPase. Biochem Biophys Res Commun, 180, 1991, 39-45
39. Maeda M, Ishizaki J, Futai M. cDNA cloning and sequence determination of pig gastric (H++K+)-ATPase. Biochem Biophys Res Commun, 157, 1988, 203-209
40. Maeda M, Oshiman K, Tamura S, Kaya S, Mahmood S, Reuben MA, Lasater LS, Sachs G, Futai M. The rat H+/K(+)-ATPase beta subunit gene and recognition of its control region by gastric DNA binding protein. J Biol Chem, 266, 1991, 21584-21588
41. Maeda M, Oshiman K, Tamura S, Futai M. Human gastric (H++K+)-ATPase gene. Similarity to (Na++K+)-ATPase genes in exon/intron organization but difference in control region. J Biol Chem, 265, 1990, 9027-9032
42. Mardh S, Norberg L. A continuous flow technique for analysis of the stoichiometry of the gastric H, K-ATPase. Acta Physiol Scand Suppl, 607, 1992, 259-263
43. Melle-Milovanovic D, Milovanovic M, Nagpal S, Sachs G, Shin JM. Regions of association between the alpha and the beta subunit of the gastric H, K-ATPase. J Biol Chem, 273, 1998, 11075-11081
44. Mendlein J, Ditmars ML, Sachs G. Calcium binding to the H+, K(+)-ATPase. Evidence for a divalent cation site that is occupied during the catalytic cycle. J Biol Chem, 265, 1990, 15590-15598
45. Mendlein J, Sachs G. The substitution of calcium for magnesium in H+, K+-ATPase catalytic cycle. Evidence for two actions of divalent cations. J Biol Chem, 264, 1989, 18512-18519
46. Mendlein J, Sachs G. Interaction of a K(+)-competitive inhibitor, a substituted imidazo[1,2a] pyridine, with the phospho- and dephosphoenzyme forms of H+, K(+)-ATPase. J Biol Chem, 265, 1990, 5030-5036
47. Moller JV, Olesen C, Winther AM, Nissen P. The sarcoplasmic Ca-ATPase: Design of a perfect chemi-osmotic pump. Q Rev Biophys 1-66, 2010.
48. Morley GP, Callaghan JM, Rose JB, Toh BH, Gleeson PA, van Driel IR. The mouse gastric H, K-ATPase beta subunit. Gene structure and co-ordinate expression with the alpha subunit during ontogeny. J Biol Chem, 267, 1992, 1165-1174
49. Munson K, Garcia R, Sachs G. Inhibitor and ion binding sites on the gastric H, K-ATPase. Biochemistry, 44, 2005, 5267-5284
50. Munson K, Law RJ, Sachs G. Analysis of the gastric H, K ATPase for ion pathways and inhibitor binding sites. Biochemistry, 46, 2007, 5398-5417
51. Munson K, Vagin O, Sachs G, Karlish S. Molecular modeling of SCH28080 binding to the gastric H, K-ATPase and MgATP interactions with SERCA- and Na, K-ATPases. Ann N Y Acad Sci, 986, 2003, 106-110
52. Munson KB, Gutierrez C, Balaji VN, Ramnarayan K, Sachs G. Identification of an extracytoplasmic region of H+, K(+)-ATPase labeled by a K(+)-competitive photoaffinity inhibitor. J Biol Chem, 266, 1991, 18976-18988
53. Murakami S, Arai I, Muramatsu M, Otomo S, Baba K, Kido T, Kozawa M. Inhibition of gastric H+, K(+)-ATPase and acid secretion by cassigarol A, a polyphenol from Cassia garrettiana Craib. Biochem Pharmacol, 44, 1992, 33-37
54. Nagaya H, Satoh H, Kubo K, Maki Y. Possible mechanism for the inhibition of gastric (H++K+)-adenosine triphosphatase by the proton pump inhibitor AG-1749. J Pharmacol Exp Ther, 248, 1989, 799-805
55. Newman PR, Greeb J, Keeton TP, Reyes AA, Shull GE. Structure of the human gastric H, K-ATPase gene and comparison of the 5'-flanking sequences of the human and rat genes. DNA Cell Biol, 9, 1990, 749-762
56. Newman PR, Shull GE. Rat gastric H, K-ATPase beta-subunit gene: Intron/exon organization, identification of multiple transcription initiation sites, and analysis of the 5'-flanking region. Genomics, 11, 1991, 252-262
57. Nilsson C, Albrektson E, Rydholm H, Rohss K, Hassan-Ali M, Hasselgren G. Tolerability, pharmacokinetics and effects on gastric acid secretion after single oral doses of the potassium-competitive acid blocker AZD0865 in healthy male subjects. Gastroenterology 128 (4 Suppl. 2): A528, 2005.
58. Nishizawa T, Abe K, Tani K, Fujiyoshi Y. Structural analysis of 2D crystals of gastric H+, K+-ATPase in different states of the transport cycle. J Struct Biol, 162, 2008, 219-228
59. Okamoto CT, Karpilow JM, Smolka A, Forte JG. Isolation and characterization of gastric microsomal glycoproteins. Evidence for a glycosylated beta-subunit of the H+/K(+)-ATPase. Biochim Biophys Acta, 1037, 1990, 360-372
60. Olesen C, Picard M, Winther AM, Gyrup C, Morth JP, Oxvig C, Moller JV, Nissen P. The structural basis of calcium transport by the calcium pump. Nature, 450, 2007, 1036-1042
61. Olesen C, Sorensen TL, Nielsen RC, Moller JV, Nissen P. Dephosphorylation of the calcium pump coupled to counterion occlusion. Science, 306, 2004, 2251-2255
62. Post RL, Toda G, Rogers FN. Phosphorylation by inorganic phosphate of sodium plus potassium ion transport adenosine triphosphatase. Four reactive states. J Biol Chem, 250, 1975, 691-701
63. Rabon EC, Gunther RD, Bassilian S, Kempner ES. Radiation inactivation analysis of oligomeric structure of the H, K-ATPase. J Biol Chem, 263, 1988, 16189-16194
64. Rabon EC, McFall TL, Sachs G. The gastric [H, K]ATPase:H+/ATP stoichiometry. J Biol Chem, 257, 1982, 6296-6299
65. Rabon EC, Reuben MA. The mechanism and structure of the gastric H, K-ATPase. Annu Rev Physiol, 52, 1990, 321-344
66. Rabon EC, Smillie K, Seru V, Rabon R. Rubidium occlusion within tryptic peptides of the H, K-ATPase. J Biol Chem 268: 8012-8018, 1993.
67. Reenstra WW, Forte JG. H+/ATP stoichiometry for the gastric (K++ H+)-ATPase. J Membr Biol, 61, 1981, 55-60
68. Reuben MA, Lasater LS, Sachs G. Characterization of a beta subunit of the gastric H+/K(+)-transporting ATPase. Proc Natl Acad Sci U S A, 87, 1990, 6767-6771
69. Richter JE, Kahrilas PJ, Johanson J, Maton P, Breiter JR, Hwang C, Marino V, Hamelin B, Levine JG. Efficacy and safety of esomeprazole compared with omeprazole in GERD patients with erosive esophagitis: A randomized controlled trial. Am J Gastroenterol, 96, 2001, 656-665
70. Sachs G, Shin JM, Besancon M, Prinz C. The continuing development of gastric acid pump inhibitors. Aliment Pharmacol Ther, 7, 1993, 4-12, discussion 29-31
71. Shin JM, Besancon M, Prinz C, Simon A, Sachs G. Continuing development of acid pump inhibitors: Site of action of pantoprazole. Aliment Pharmacol Ther, 8, 1994, 11-23
72. Shin JM, Besancon M, Simon A, Sachs G. The site of action of pantoprazole in the gastric H+/K(+)-ATPase. Biochim Biophys Acta, 1148, 1993, 223-233
73. Shin JM, Cho YM, Sachs G. Chemistry of covalent inhibition of the gastric (H+, K+)-ATPase by proton pump inhibitors. J Am Chem Soc, 126, 2004, 7800-7811
74. Shin JM, Goldshleger R, Munson KB, Sachs G, Karlish SJ. Selective Fe2+-catalyzed oxidative cleavage of gastric H+, K+-ATPase: Implications for the energy transduction mechanism of P-type cation pumps. J Biol Chem, 276, 2001, 48440-48450
75. Shin JM, Homerin M, Domagala F, Ficheux H, Sachs G. Characterization of the inhibitory activity of tenatoprazole on the gastric H+, K+-ATPase in vitro and in vivo. Biochem Pharmacol, 71, 2006, 837-849
76. Shin JM, Sachs G. Identification of a region of the H, K-ATPase alpha subunit associated with the beta subunit. J Biol Chem, 269, 1994, 8642-8646
77. Shin JM, Sachs G. Dimerization of the gastric H+, K(+)-ATPase. J Biol Chem, 271, 1996, 1904-1908
78. Shin JM, Sachs G. Differences in binding properties of two proton pump inhibitors on the gastric H(+), K(+)-ATPase in vivo. Biochem Pharmacol, 68, 2004, 2117-2127
79. Shin JM, Sachs G. Functional consequences of the oligomeric form of the membrane-bound gastric H, K-ATPase. Biochemistry, 44, 2005, 16321-16332
80. Shin JM, Sachs G, Cho YM, Garst M. 1-Arylsulfonyl-2-(pyridylmethylsulfinyl) benzimidazoles as new proton pump inhibitor prodrugs. Molecules, 14, 2009, 5247-5280
81. Shull GE. cDNA cloning of the beta-subunit of the rat gastric H, KATPase. J Biol Chem, 265, 1990, 12123-12126
82. Shull GE, Lingrel JB. Molecular cloning of the rat stomach (H+ + K+)-ATPase. J Biol Chem, 261, 1986, 16788-16791
83. Simon WA, Budingen C, Fahr S, Kinder B, Koske M. The H+, K(+)-ATPase inhibitor pantoprazole (BY1023/SK&F96022) interacts less with cytochrome P450 than omeprazole and lansoprazole. Biochem Pharmacol, 42, 1991, 347-355
84. Simon WA, Herrmann M, Klein T, Shin JM, Huber R, Senn-Bilfinger J, Postius S. Soraprazan: Setting new standards in inhibition of gastric acid secretion. J Pharmacol Exp Ther, 321, 2007, 866-874
85. Skrabanja AT, van der Hijden HT, De Pont JJ. Transport ratios of reconstituted (H+ + K+)-ATPase. Biochim Biophys Acta, 903, 1987, 434-440
86. Smith GS, Scholes PB. The H+/ATP stoichiometry of the (H++K+)-ATPase of dog gastric microsomes. Biochim Biophys Acta, 688, 1982, 803-807
87. Sorensen TL, Olesen C, Jensen AM, Moller JV, Nissen P. Crystals of sarcoplasmic reticulum Ca(2+)-ATPase. J Biotechnol, 124, 2006, 704-716
88. Swarts HG, Koenderink JB, Willems PH, Krieger E, De Pont JJ. Asn792 participates in the hydrogen bond network around the K+-binding pocket of gastric H, K-ATPase. J Biol Chem, 280, 2005, 11488-11494
89. Takahashi M, Kondou Y, Toyoshima C. Interdomain communication in calcium pump as revealed in the crystal structures with transmembrane inhibitors. Proc Natl Acad Sci U S A, 104, 2007, 5800-5805
90. Toh BH, Gleeson PA, Simpson RJ, Moritz RL, Callaghan JM, Goldkorn I, Jones CM, Martinelli TM, Mu FT, Humphris DC, et al. The 60- to 90-kDa parietal cell autoantigen associated with autoimmune gastritis is a beta subunit of the gastric H+/K(+)-ATPase (proton pump). Proc Natl Acad Sci U S A, 87, 1990, 6418-6422
91. Toyoshima C, Asahi M, Sugita Y, Khanna R, Tsuda T, MacLennan DH. Modeling of the inhibitory interaction of phospholamban with the Ca2+ ATPase. Proc Natl Acad Sci U S A, 100, 2003, 467-472
92. Toyoshima C, Nakasako M, Nomura H, Ogawa H. Crystal structure of the calcium pump of sarcoplasmic reticulum at 2.6 Å resolution. Nature, 405, 2000, 647-655
93. Toyoshima C, Nomura H. Structural changes in the calcium pump accompanying the dissociation of calcium. Nature, 418, 2002, 605-611
94. Toyoshima C, Nomura H, Sugita Y. Crystal structures of Ca2+-ATPase in various physiological states. Ann N Y Acad Sci, 986, 2003, 1-8
95. Tyagarajan K, Lipniunas PH, Townsend RR, Forte JG. The N-linked oligosaccharides of the beta-subunit of rabbit gastric H, K-ATPase: Site localization and identification of novel structures. Biochemistry, 36, 1997, 10200-10212
96. Tyagarajan K, Townsend RR, Forte JG. The Beta-subunit of the rabbit H, K-ATPase: A glycoprotein with all terminal lactosamine units capped with alpha-linked galactose residues. Biochemistry, 35, 1996, 3238-3246
97. Vagin O, Denevich S, Sachs G. Plasma membrane delivery of the gastric H, K-ATPase: The role of beta-subunit glycosylation. Am J Physiol Cell Physiol, 285, 2003, C968-C976
98. Vagin O, Kraut JA, Sachs G. Role of N-glycosylation in trafficking of apical membrane proteins in epithelia. Am J Physiol Renal Physiol, 296, 2009, F459-F469
99. Vagin O, Turdikulova S, Sachs G. The H, K-ATPase beta subunit as a model to study the role of N-glycosylation in membrane trafficking and apical sorting. J Biol Chem, 279, 2004, 39026-39034
100. Vagin O, Turdikulova S, Yakubov I, Sachs G. Use of the H, K-ATPase beta subunit to identify multiple sorting pathways for plasma membrane delivery in polarized cells. J Biol Chem, 280, 2005, 14741-14754
101. Walderhaug MO, Post RL, Saccomani G, Leonard RT, Briskin DP. Structural relatedness of three ion-transport adenosine triphosphatases around their active sites of phosphorylation. J Biol Chem, 260, 1985, 3852-3859
102. Wallmark B, Brandstrom A, Larsson H. Evidence for acid-induced transformation of omeprazole into an active inhibitor of (H+ + K+)-ATPase within the parietal cell. Biochim Biophys Acta, 778, 1984, 549-558
103. Wallmark B, Briving C, Fryklund J, Munson K, Jackson R, Mendlein J, Rabon E, Sachs G. Inhibition of gastric H+, K+-ATPase and acid secretion by SCH 28080, a substituted pyridyl(1,2a)imidazole. J Biol Chem, 262, 1987, 2077-2084
104. Wallmark B, Stewart HB, Rabon E, Saccomani G, Sachs G. The catalytic cycle of gastric (H+ + K+)-ATPase. J Biol Chem, 255, 1980, 5313-5319
105. Zimmermann PJ, Buhr W, Brehm C, Palmer AM, Feth MP, Senn-Bilfinger J, Simon WA. Novel indanyl-substituted imidazo[1,2-a]pyridines as potent reversible inhibitors of the gastric H+/K+-ATPase. Bioorg Med Chem Lett, 17, 2007, 5374-5378
106. Ogawa H, Shinoda T, Cornelius F, Toyoshima C. Crystal structure of the sodium-potassium pump (Na+, K+-ATPase) with bound potassium and ouabain. Proc Natl Acad Sci U S A, 106, 2009, 13742-13747
107. Shin JM, Munson K, Vagin O, Sachs G. The gastric HK-ATPase: Structure, function, and inhibition. Pflugers Arch, 457, 2009, 609-622
108. Shin JM, Vagin O, Munson K, Kidd M, Modlin IM, Sachs G. Molecular mechanisms in therapy of acid-related diseases. Cell Mol Life Sci, 65, 2008, 264-281
109. Shinoda T, Ogawa H, Cornelius F, Toyoshima C. Crystal structure of the sodium-potassium pump at 2.4 Å resolution. Nature, 459, 2009, 446-450
110. Vagin O, Tokhtaeva E, Yakubov I, Shevchenko E, Sachs G. Inverse correlation between the extent of N-glycan branching and intercellular adhesion in epithelia. Contribution of the Na, K-ATPase beta1 subunit. J Biol Chem 283: 2192-2202, 2008. Volume 1, October 2011 2153